Neuralink's Brain Implant Approved For Human Trial

The brain implant company Neuralink founded by Elon Musk previously tested implants in pigs and monkeys. Now it has gained approval for human trials, Timothy Revell reported for New Scientist.

Photo Insert: Neuralink was formed in 2016 by Elon Musk and a group of scientists and engineers with the ultimate aim of making devices that interface with the human brain.

Neuralink announced on 25 May that it has received approval from the US Food and Drug Administration (FDA) for a clinical study in humans. Neuralink made the announcement on Twitter: “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study.”

The tweet said that the approval “represents an important first step that will one day allow our technology to help many people.”

The firm also said that the recruitment is not yet open for the trial, and it has yet to give any further details about what the trial will entail.

Neuralink was formed in 2016 by Elon Musk and a group of scientists and engineers with the ultimate aim of making devices that interface with the human brain – both reading information from neurons as well as feeding information directly back into the brain. So far the company has had mixed success.

WEEKLY FEATURE : MVP Group Keeps Lights On During Pandemic